A retrospective study of Real-World Use of Cladribine Tablets in Portugal
Latest Information Update: 09 Dec 2022
At a glance
- Drugs Cladribine (Primary) ; Interferon beta-1a; Natalizumab; Ocrelizumab
- Indications Multiple sclerosis
- Focus Therapeutic Use
Most Recent Events
- 09 Dec 2022 New trial record
- 09 Nov 2022 Results presented at the 25th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research